Your browser doesn't support javascript.
loading
COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models.
Xu, Lihong; Stevens, Janine; Hilton, Mary Beth; Seaman, Steven; Conrads, Thomas P; Veenstra, Timothy D; Logsdon, Daniel; Morris, Holly; Swing, Deborah A; Patel, Nimit L; Kalen, Joseph; Haines, Diana C; Zudaire, Enrique; St Croix, Brad.
Afiliación
  • Xu L; Tumor Angiogenesis Section, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI) at Frederick, National Institutes of Health, Frederick, MD 21702, USA.
  • Stevens J; Tumor Angiogenesis Section, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI) at Frederick, National Institutes of Health, Frederick, MD 21702, USA.
  • Hilton MB; Tumor Angiogenesis Section, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI) at Frederick, National Institutes of Health, Frederick, MD 21702, USA. Basic Research Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Seaman S; Tumor Angiogenesis Section, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI) at Frederick, National Institutes of Health, Frederick, MD 21702, USA.
  • Conrads TP; Laboratory of Proteomics and Analytical Technologies, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Veenstra TD; Laboratory of Proteomics and Analytical Technologies, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Logsdon D; Basic Research Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Morris H; Transgenic Core Facility, MCGP, NCI, Frederick, MD 21702, USA.
  • Swing DA; Transgenic Core Facility, MCGP, NCI, Frederick, MD 21702, USA.
  • Patel NL; Small Animal Imaging Program/LASP, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Kalen J; Small Animal Imaging Program/LASP, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Haines DC; Pathology/Histotechnology Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Zudaire E; Tumor Angiogenesis Section, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI) at Frederick, National Institutes of Health, Frederick, MD 21702, USA.
  • St Croix B; Tumor Angiogenesis Section, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI) at Frederick, National Institutes of Health, Frederick, MD 21702, USA. stcroix@ncifcrf.gov.
Sci Transl Med ; 6(242): 242ra84, 2014 Jun 25.
Article en En | MEDLINE | ID: mdl-24964992
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inhibidores de la Angiogénesis / Ensayos Antitumor por Modelo de Xenoinjerto / Inhibidores de la Ciclooxigenasa 2 / Neoplasias Hepáticas / Neoplasias Mamarias Experimentales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inhibidores de la Angiogénesis / Ensayos Antitumor por Modelo de Xenoinjerto / Inhibidores de la Ciclooxigenasa 2 / Neoplasias Hepáticas / Neoplasias Mamarias Experimentales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos